South Africa's laboratory medicine sector is demonstrating active growth from both commercial and clinical perspectives. This growth is driven by increased demand for automation, advanced diagnostic platforms, and point-of-care testing, which occurs concurrently with the expansion of the hospital network.
South Africa possesses one of the largest and most developed laboratory networks in Africa. The expansion of hospital infrastructure in both the public and private sectors is accelerating to meet the growing need for faster and more accurate diagnostic services. The simultaneous development of public and private medical institutions strengthens the scaling of infrastructure, which forms the basis for the demand for laboratory automation and advanced diagnostics.
According to the GlobalData/MarketLine industry profile for 2025, the South African healthcare market was valued at $40.3 million in 2024. It showed a Compound Annual Growth Rate (CAGR) of 4.6% from 2019 to 2024 and is projected to reach $48.7 million by 2029 while maintaining a growth rate of 3.8%, providing a foundation for long-term investment rather than one-off expenditures.
The World Health Expo (WHX) 2026 will take place in Johannesburg from October 6 to 8 at the Gallagher Convention Centre. The event will gather leaders in laboratory medicine, hospital infrastructure executives, procurement specialists, and healthcare investors. Thanks to the dedicated Laboratory Zone and the Lab Leadership Indaba meeting, jointly organized with the National Health Service (NHLS), WHX will bring together decision-makers who are assessing technologies, partnerships, and investment opportunities shaping the next phase of sector development.
Professor Koleka Mlisana, CEO of NHLS, noted: 'The demand for laboratory services in South Africa exceeds historical levels, driven by the expansion of the hospital network, the burden of chronic diseases, and the need for faster and more accurate turnaround times.' He emphasized that 'laboratory capacity is no longer a supporting function; it plays a central role in clinical decision-making, patient flow, and hospital throughput.'
The Laboratory Zone at WHX is dedicated to suppliers of solutions for laboratory automation, diagnostics, and point-of-care testing. The entire exhibition is expected to host over 10,000 visitors and 600 exhibitors from more than 60 countries, allowing for the gathering of suppliers and healthcare decision-makers from across the sector.
Tom Coleman, Healthcare Portfolio Director at inD, organizer of WHX, stated: 'Market signals are clear: investments are flowing into laboratory and diagnostic infrastructure because it delivers proven clinical and operational value.' He added that 'suppliers and investors are evaluating market entry and expansion based on demonstrated demand, hospital network growth, and the need for faster, decentralized testing.'